Control of Metabolic and Cardiovascular Risk in Patients With Schizophrenia and Overweight
Clinical trial NCT00584519 · COMPLETED
Trial details
- NCT number
- NCT00584519
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2007-06-01
- Primary completion
- 2009-06-01
- Enrollment
- 430
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.